Abstract
c-Yes is a member of Src tyrosine kinase family and it is over expressed in human colorectal cancer cells. c-Yes tyrosine kinase is an attractive target due to its inhibition controls colon tumorigenesis, metastasis and angiogenesis. High throughput virtual screening and docking methods were employed to identify novel inhibitors based on the three dimensional structure of c-Yes. Kinase domain of c-Yes is modelled with reference to the crystal structure available for Src kinase structure and simulated for 100 ns to obtain ensembles with distinct conformation of the active site. Seven ensembles obtained from molecular dynamics (MD) trajectory and one homology model were used to screen library of the 2 million Enamine HTS compounds. A library of 159 Src kinase inhibitors and 6319 associated decoys is used for validation. Based on the score values, 25 compounds were shortlisted and reported as novel inhibitors of c-Yes kinase for further development of potent drugs to treat colorectal cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Summy, J.M., Gallick, G.E.: Src family kinases in tumor progression and metastasis. Cancer Metastasis Reviews 22, 337–358 (2003)
Pena, S.V., Melhem, M.F., Meisler, A.I., Cartwright, C.A.: Elevated c-yes tyrosine kinase activity in premalignant lesions of the colon. Gastroenterology 108, 117–124 (1995)
Sancier, F., Dumont, A., Sirvent, A., Paquay de Plater, L., Edmonds, T., David, G., Jan, M., de Montrion, C., Coge, F., Leonce, S., Burbridge, M., Bruno, A., Boutin, J.A., Lockhart, B., Roche, S., Cruzalegui, F.: Specific oncogenic activity of the Src-family tyrosine kinase c-Yes in colon carcinoma cells. PloS One 6, e17237 (2011)
Stein, P.L., Vogel, H., Soriano, P.: Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes & Development 8, 1999–2007 (1994)
Roche, S., Fumagalli, S., Courtneidge, S.A.: Requirement for Src family protein tyrosine kinases in G2 for fibroblast cell division. Science 269, 1567–1569 (1995)
Hirsch, A.J., Medigeshi, G.R., Meyers, H.L., DeFilippis, V., Fruh, K., Briese, T., Lipkin, W.I., Nelson, J.A.: The Src family kinase c-Yes is required for maturation of West Nile virus particles. Journal of Virology 79, 11943–11951 (2005)
Xu, W., Doshi, A., Lei, M., Eck, M.J., Harrison, S.C.: Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Molecular Cell 3, 629–638 (1999)
Lombardo, L.J., Lee, F.Y., Chen, P., Norris, D., Barrish, J.C., Behnia, K., Castaneda, S., Cornelius, L.A., Das, J., Doweyko, A.M., Fairchild, C., Hunt, J.T., Inigo, I., Johnston, K., Kamath, A., Kan, D., Klei, H., Marathe, P., Pang, S., Peterson, R., Pitt, S., Schieven, G.L., Schmidt, R.J., Tokarski, J., Wen, M.L., Wityak, J., Borzilleri, R.M.: Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. Journal of Medicinal Chemistry 47, 6658–6661 (2004)
Chen, P., Doweyko, A.M., Norris, D., Gu, H.H., Spergel, S.H., Das, J., Moquin, R.V., Lin, J., Wityak, J., Iwanowicz, E.J., McIntyre, K.W., Shuster, D.J., Behnia, K., Chong, S., de Fex, H., Pang, S., Pitt, S., Shen, D.R., Thrall, S., Stanley, P., Kocy, O.R., Witmer, M.R., Kanner, S.B., Schieven, G.L., Barrish, J.C.: Imidazoquinoxaline Src-family kinase p56Lck inhibitors: SAR, QSAR, and the discovery of (S)-N-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-a]pyrido[3,2-e]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo antiinflammatory activity. Journal of Medicinal Chemistry 47, 4517–4529 (2004)
Guan, H., Laird, A.D., Blake, R.A., Tang, C., Liang, C.: Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones as selective and potent inhibitors of Src and Yes tyrosine kinase. Bioorganic & Medicinal Chemistry Letters 14, 187–190 (2004)
Noronha, G., Barrett, K., Cao, J., Dneprovskaia, E., Fine, R., Gong, X., Gritzen, C., Hood, J., Kang, X., Klebansky, B., Li, G., Liao, W., Lohse, D., Mak, C.C., McPherson, A., Palanki, M.S., Pathak, V.P., Renick, J., Soll, R., Splittgerber, U., Wrasidlo, W., Zeng, B., Zhao, N., Zhou, Y.: Discovery and preliminary structure-activity relationship studies of novel benzotriazine based compounds as Src inhibitors. Bioorganic & Medicinal Chemistry Letters 16, 5546–5550 (2006)
Hu, S.X., Soll, R., Yee, S., Lohse, D.L., Kousba, A., Zeng, B., Yu, X., McPherson, A., Renick, J., Cao, J., Tabak, A., Hood, J., Doukas, J., Noronha, G., Martin, M.: Metabolism and pharmacokinetics of a novel Src kinase inhibitor TG100435 ([7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-y l-ethoxy)-phenyl]-amine) and its active N-oxide metabolite TG100855 ([7-(2,6-dichloro-phenyl)-5-methylbenzo[1,2,4]triazin-3-yl]-{4-[2-(1-oxy-pyrrolid in-1-yl)-ethoxy]-phenyl}-amine). Drug Metabolism and Disposition: the Biological Fate of Chemicals 35, 929–936 (2007)
Palanki, M.S., Akiyama, H., Campochiaro, P., Cao, J., Chow, C.P., Dellamary, L., Doukas, J., Fine, R., Gritzen, C., Hood, J.D., Hu, S., Kachi, S., Kang, X., Klebansky, B., Kousba, A., Lohse, D., Mak, C.C., Martin, M., McPherson, A., Pathak, V.P., Renick, J., Soll, R., Umeda, N., Yee, S., Yokoi, K., Zeng, B., Zhu, H., Noronha, G.: Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotria zin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration. Journal of Medicinal Chemistry 51, 1546–1559 (2008)
Remsing Rix, L.L., Rix, U., Colinge, J., Hantschel, O., Bennett, K.L., Stranzl, T., Muller, A., Baumgartner, C., Valent, P., Augustin, M., Till, J.H., Superti-Furga, G.: Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells. Leukemia 23, 477–485 (2009)
Huber, K., Brault, L., Fedorov, O., Gasser, C., Filippakopoulos, P., Bullock, A.N., Fabbro, D., Trappe, J., Schwaller, J., Knapp, S., Bracher, F.: 7,8-dichloro-1-oxo-beta-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes. Journal of Medicinal Chemistry 55, 403–413 (2012)
Urich, R., Wishart, G., Kiczun, M., Richters, A., Tidten-Luksch, N., Rauh, D., Sherborne, B., Wyatt, P.G., Brenk, R.: De novo design of protein kinase inhibitors by in silico identification of hinge region-binding fragments. ACS Chemical Biology 8, 1044–1052 (2013)
Chen, I.J., Foloppe, N.: Drug-like bioactive structures and conformational coverage with the LigPrep/ConfGen suite: comparison to programs MOE and catalyst. Journal of Chemical Information and Modeling 50, 822–839 (2010)
Peng, Y., Kaminski, G.A.: Accurate determination of pyridine-poly(amidoamine) dendrimer absolute binding constants with the OPLS-AA force field and direct integration of radial distribution functions. The Journal of Physical Chemistry B 109, 15145–15149 (2005)
Friesner, R.A., Banks, J.L., Murphy, R.B., Halgren, T.A., Klicic, J.J., Mainz, D.T., Repasky, M.P., Knoll, E.H., Shelley, M., Perry, J.K., Shaw, D.E., Francis, P., Shenkin, P.S.: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. Journal of Medicinal Chemistry 47, 1739–1749 (2004)
Halgren, T.A., Murphy, R.B., Friesner, R.A., Beard, H.S., Frye, L.L., Pollard, W.T., Banks, J.L.: Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry 47, 1750–1759 (2004)
Pronk, S., Pall, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., Shirts, M.R., Smith, J.C., Kasson, P.M., van der Spoel, D., Hess, B., Lindahl, E.: GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29, 845–854 (2013)
Ramachandran, G.N., Ramakrishnan, C., Sasisekharan, V.: Stereochemistry of polypeptide chain configurations. J. Mol. Biol. 7, 95–99 (1963)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this paper
Cite this paper
Ramakrishnan, C., Thangakani, A.M., Velmurugan, D., Gromiha, M.M. (2014). Identification of Novel c-Yes Kinase Inhibitors. In: Huang, DS., Han, K., Gromiha, M. (eds) Intelligent Computing in Bioinformatics. ICIC 2014. Lecture Notes in Computer Science(), vol 8590. Springer, Cham. https://doi.org/10.1007/978-3-319-09330-7_57
Download citation
DOI: https://doi.org/10.1007/978-3-319-09330-7_57
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09329-1
Online ISBN: 978-3-319-09330-7
eBook Packages: Computer ScienceComputer Science (R0)